Traditional drug development involves testing millions of compounds physically. AI bypasses much of this inefficiency by predicting compound efficacy and toxicity in silico (via computer simulation) before the compound ever reaches a lab bench.
Key AI Applications:
- Target Identification: Instead of guessing what biological pathway to focus on, AI analyzes massive datasets (genomics, proteomes) to pinpoint the most vulnerable and promising molecular ‘targets’ for intervention.
- Virtual Screening: Using Machine Learning models, AI can screen billions of virtual compounds against a specific target. This process narrows the focus to the handful of most promising candidates, saving years of lab time.
- De Novo Design: This is perhaps the most revolutionary aspect. Rather than finding a drug that fits an existing target, AI can actively design a novel molecular structure from scratch that is optimized to interact perfectly with the target.
About the Author
